BioAdvance News

QR Pharma, Inc. Presents New Data on Posiphen in Alzheimer’s and Parkinson’s Disease at the 13th AD/PD International Conference

By WebmasterMarch 16, 2017November 1st, 2024No Comments

QR Pharma, Inc. Presents New Data on Posiphen in Alzheimer’s and Parkinson’s Disease at the 13th AD/PD International Conference

Previous PostIntezyne Technologies Initiates First-In-Human Trials for Topoisomerase-1 Inhibitor IT-141; GRP78 Inhibitor IT-139 to be Featured in AACR Symposium
Next PostImmigrant-founded Keriton raised $1 million to help keep premature babies on breast milk